Beraprost


Beraprost

An oral prostacyclin PGI2 analogue with vasodilator, antiplatelet, and cytoprotective effects, used to manage pulmonary arterial hypertension. Beraprost improves exercise capacity and symptoms in NYHA-functional class-II and -III patients with PAH and, in particular, in those with primary pulmonary hypertension.
Adverse effects
Headache, facial flushing, vasodilation.

Beraprost®

Epoprostenol A formulation of prostacyclin in trials for pulmonary vascular disease 2º to treatment with diet drugs